UniProt ID | RU17_HUMAN | |
---|---|---|
UniProt AC | P08621 | |
Protein Name | U1 small nuclear ribonucleoprotein 70 kDa | |
Gene Name | SNRNP70 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 437 | |
Subcellular Localization | Nucleus. Nucleus speckle. Nucleus, nucleoplasm. Colocalizes with SCNM1 and LUC7L2 in nuclear speckles.. | |
Protein Description | Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome. SNRNP70 binds to the loop I region of U1-snRNA. The truncated isoforms cannot bind U1-snRNA.. | |
Protein Sequence | MTQFLPPNLLALFAPRDPIPYLPPLEKLPHEKHHNQPYCGIAPYIREFEDPRDAPPPTRAETREERMERKRREKIERRQQEVETELKMWDPHNDPNAQGDAFKTLFVARVNYDTTESKLRREFEVYGPIKRIHMVYSKRSGKPRGYAFIEYEHERDMHSAYKHADGKKIDGRRVLVDVERGRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYMESEGGDGYLAPENGYLMEAAPE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MTQFLPPNL ------CCCCCCHHH | 28.20 | 22223895 | |
21 | Phosphorylation | APRDPIPYLPPLEKL CCCCCCCCCCCHHHC | 32.34 | 28152594 | |
27 (in isoform 2) | Ubiquitination | - | 75.01 | 21890473 | |
27 (in isoform 3) | Ubiquitination | - | 75.01 | 21890473 | |
27 | Acetylation | PYLPPLEKLPHEKHH CCCCCHHHCCCCCCC | 75.01 | 23236377 | |
27 (in isoform 1) | Ubiquitination | - | 75.01 | 21890473 | |
27 | Ubiquitination | PYLPPLEKLPHEKHH CCCCCHHHCCCCCCC | 75.01 | 21890473 | |
32 | Acetylation | LEKLPHEKHHNQPYC HHHCCCCCCCCCCCC | 47.32 | 21466224 | |
38 | Phosphorylation | EKHHNQPYCGIAPYI CCCCCCCCCCCHHHH | 8.11 | 28152594 | |
39 | Glutathionylation | KHHNQPYCGIAPYIR CCCCCCCCCCHHHHH | 3.96 | 22555962 | |
58 | O-linked_Glycosylation | PRDAPPPTRAETREE CCCCCCCCHHHHHHH | 48.57 | 28510447 | |
84 | Phosphorylation | RRQQEVETELKMWDP HHHHHHHHHHHHCCC | 52.36 | 21406692 | |
87 (in isoform 2) | Ubiquitination | - | 31.54 | 21890473 | |
87 (in isoform 1) | Ubiquitination | - | 31.54 | 21890473 | |
87 (in isoform 3) | Ubiquitination | - | 31.54 | 21890473 | |
87 | Ubiquitination | QEVETELKMWDPHND HHHHHHHHHCCCCCC | 31.54 | 21906983 | |
87 | Acetylation | QEVETELKMWDPHND HHHHHHHHHCCCCCC | 31.54 | 26051181 | |
103 | Ubiquitination | NAQGDAFKTLFVARV CCCCHHHHHEEEEEE | 46.14 | 21890473 | |
103 (in isoform 3) | Ubiquitination | - | 46.14 | 21890473 | |
103 (in isoform 1) | Ubiquitination | - | 46.14 | 21890473 | |
103 (in isoform 2) | Ubiquitination | - | 46.14 | 21890473 | |
103 | Acetylation | NAQGDAFKTLFVARV CCCCHHHHHEEEEEE | 46.14 | 26051181 | |
112 | Phosphorylation | LFVARVNYDTTESKL EEEEEECCCCCHHHH | 16.29 | 29116813 | |
114 | Phosphorylation | VARVNYDTTESKLRR EEEECCCCCHHHHHH | 23.31 | 29116813 | |
115 | Phosphorylation | ARVNYDTTESKLRRE EEECCCCCHHHHHHH | 35.05 | 29116813 | |
117 | Phosphorylation | VNYDTTESKLRREFE ECCCCCHHHHHHHEE | 34.59 | 21815630 | |
118 | Ubiquitination | NYDTTESKLRREFEV CCCCCHHHHHHHEEE | 39.52 | 19608861 | |
118 | 2-Hydroxyisobutyrylation | NYDTTESKLRREFEV CCCCCHHHHHHHEEE | 39.52 | - | |
118 | Acetylation | NYDTTESKLRREFEV CCCCCHHHHHHHEEE | 39.52 | 19608861 | |
126 | Phosphorylation | LRREFEVYGPIKRIH HHHHEEEECCEEEEE | 15.24 | 23401153 | |
130 (in isoform 2) | Ubiquitination | - | 48.73 | 21890473 | |
130 (in isoform 1) | Ubiquitination | - | 48.73 | 21890473 | |
130 | Acetylation | FEVYGPIKRIHMVYS EEEECCEEEEEEEEE | 48.73 | 25953088 | |
130 | Methylation | FEVYGPIKRIHMVYS EEEECCEEEEEEEEE | 48.73 | - | |
130 | Ubiquitination | FEVYGPIKRIHMVYS EEEECCEEEEEEEEE | 48.73 | 21890473 | |
130 (in isoform 3) | Ubiquitination | - | 48.73 | 21890473 | |
136 | Phosphorylation | IKRIHMVYSKRSGKP EEEEEEEEECCCCCC | 10.82 | 25839225 | |
137 | Phosphorylation | KRIHMVYSKRSGKPR EEEEEEEECCCCCCC | 15.35 | 12548559 | |
140 | Phosphorylation | HMVYSKRSGKPRGYA EEEEECCCCCCCEEE | 55.71 | 22817900 | |
146 | Phosphorylation | RSGKPRGYAFIEYEH CCCCCCEEEEEEEEC | 10.30 | 28152594 | |
151 | Phosphorylation | RGYAFIEYEHERDMH CEEEEEEEECHHHHH | 20.12 | 28152594 | |
162 | Acetylation | RDMHSAYKHADGKKI HHHHHHHCCCCCCEE | 31.84 | 23749302 | |
180 | Methylation | RVLVDVERGRTVKGW EEEEECCCCCEECCC | 39.48 | 12018419 | |
185 | Ubiquitination | VERGRTVKGWRPRRL CCCCCEECCCCCCCC | 52.74 | - | |
199 | Phosphorylation | LGGGLGGTRRGGADV CCCCCCCCCCCCCCC | 18.52 | 21406692 | |
201 | Methylation | GGLGGTRRGGADVNI CCCCCCCCCCCCCEE | 47.97 | 12018431 | |
211 | Phosphorylation | ADVNIRHSGRDDTSR CCCEEECCCCCCCCC | 26.19 | 28985074 | |
216 | Phosphorylation | RHSGRDDTSRYDERP ECCCCCCCCCCCCCC | 21.28 | 23927012 | |
217 | Phosphorylation | HSGRDDTSRYDERPG CCCCCCCCCCCCCCC | 35.52 | 23927012 | |
219 | Phosphorylation | GRDDTSRYDERPGPS CCCCCCCCCCCCCCC | 23.17 | 23927012 | |
226 | Phosphorylation | YDERPGPSPLPHRDR CCCCCCCCCCCCCCC | 45.01 | 29255136 | |
226 | O-linked_Glycosylation | YDERPGPSPLPHRDR CCCCCCCCCCCCCCC | 45.01 | OGP | |
245 | Phosphorylation | ERERRERSRERDKER HHHHHHHHHHHHHHH | 33.47 | 17081983 | |
250 (in isoform 4) | Ubiquitination | - | 65.96 | 21906983 | |
257 | Phosphorylation | KERERRRSRSRDRRR HHHHHHHHHHHHHHH | 32.56 | 20068231 | |
259 | Phosphorylation | RERRRSRSRDRRRRS HHHHHHHHHHHHHHH | 39.52 | 20068231 | |
266 | Phosphorylation | SRDRRRRSRSRDKEE HHHHHHHHHHHHHHH | 32.56 | 30576142 | |
268 | Phosphorylation | DRRRRSRSRDKEERR HHHHHHHHHHHHHHH | 46.18 | 23882029 | |
277 | Phosphorylation | DKEERRRSRERSKDK HHHHHHHHHHHHHHH | 36.36 | - | |
281 | Phosphorylation | RRRSRERSKDKDRDR HHHHHHHHHHHHHHH | 40.22 | 24144214 | |
292 | Phosphorylation | DRDRKRRSSRSRERA HHHHHHHHHHHHHHH | 33.85 | 26657352 | |
293 | Phosphorylation | RDRKRRSSRSRERAR HHHHHHHHHHHHHHH | 32.25 | 20068231 | |
295 | Phosphorylation | RKRRSSRSRERARRE HHHHHHHHHHHHHHH | 40.20 | 26657352 | |
310 | Methylation | RERKEELRGGGGDMA HHHHHHHCCCCCCCC | 45.02 | 115917365 | |
320 | Phosphorylation | GGDMAEPSEAGDAPP CCCCCCCCCCCCCCC | 31.42 | 25159151 | |
337 (in isoform 2) | Ubiquitination | - | 56.88 | 21890473 | |
346 | Acetylation | GPDGPEEKGRDRDRE CCCCCCCCCCHHHHH | 58.55 | 26051181 | |
346 | Methylation | GPDGPEEKGRDRDRE CCCCCCCCCCHHHHH | 58.55 | 117839601 | |
346 (in isoform 1) | Ubiquitination | - | 58.55 | 21890473 | |
346 | Ubiquitination | GPDGPEEKGRDRDRE CCCCCCCCCCHHHHH | 58.55 | 2190698 | |
346 | Sumoylation | GPDGPEEKGRDRDRE CCCCCCCCCCHHHHH | 58.55 | 28112733 | |
357 | Phosphorylation | RDRERRRSHRSERER HHHHHHHHHHHHHHH | 22.80 | 20068231 | |
360 | Phosphorylation | ERRRSHRSERERRRD HHHHHHHHHHHHHHH | 35.27 | 20068231 | |
385 | Phosphorylation | HKRGERGSERGRDEA HHHCCCCHHHCCCCC | 30.27 | 30576142 | |
393 | Methylation | ERGRDEARGGGGGQD HHCCCCCCCCCCCCC | 42.09 | 115917369 | |
410 | Phosphorylation | LEGLGNDSRDMYMES CCCCCCCCCCEEECC | 33.89 | 19664994 | |
414 | Phosphorylation | GNDSRDMYMESEGGD CCCCCCEEECCCCCC | 11.30 | 26074081 | |
417 | Phosphorylation | SRDMYMESEGGDGYL CCCEEECCCCCCCEE | 25.63 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
226 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RU17_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RU17_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-118 AND LYS-162, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND MASSSPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-410, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-320 ANDSER-410, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-410, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-410, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-266; SER-268;SER-320 AND SER-410, AND MASS SPECTROMETRY. | |
"Robust phosphoproteomic profiling of tyrosine phosphorylation sitesfrom human T cells using immobilized metal affinity chromatography andtandem mass spectrometry."; Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,Peters E.C.; Anal. Chem. 76:2763-2772(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-126, AND MASSSPECTROMETRY. |